Search research articles
Contact Us
Filters
Showing results (161-170 of 939) with videos related to
Page
of 94
Sort By:
Research Communications in Chemical Pathology and Pharmacology
|
December 1, 1987
Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats
R W Fuller, H D Snoddy
Brain Research
|
December 27, 1974
Long-lasting depletion of brain serotonin by 4-chloroamphetamine in guinea pigs
R W Fuller, K W Perry
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1979
Inability of imipramine to protect against type A or type B monoamine oxidase inhibition by pargyline
R W Fuller, S K Hemrick
Biochemical and Biophysical Research Communications
|
June 18, 1974
Increased conversion of a phenylalanine load to tyrosine in tetraiodoglucagon-treated rats
R W Fuller, J C Baker
BMJ Open
|
February 22, 2023
Cohort study assessing the impact of COVID-19 on venous leg ulcer management and associated clinical outcomes in clinical practice in the UK
Julian F Guest, Graham W Fuller
Comparative Biochemistry and Physiology. B, Comparative Biochemistry
|
October 15, 1973
Binding of tryptophan to plasma proteins in several species
R W Fuller, B W Roush
The Journal of Pharmacy and Pharmacology
|
November 1, 1977
Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors
R W Fuller, K W Perry
The European Respiratory Journal
|
September 1, 1989
The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness
P M O'Byrne, R W Fuller
The Journal of Burn Care & Rehabilitation
|
November 1, 1988
Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey
F W Fuller, P E Engler
The Journal of Pharmacy and Pharmacology
|
March 1, 1979
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine
R W Fuller, H D Snoddy
Page
of 94
Search research articles
Search
Showing results (161-170 of 939) with videos related to
Sort By:
Page
of 94
Research Communications in Chemical Pathology and Pharmacology
|
December 1, 1987
Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats
R W Fuller, H D Snoddy
Brain Research
|
December 27, 1974
Long-lasting depletion of brain serotonin by 4-chloroamphetamine in guinea pigs
R W Fuller, K W Perry
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1979
Inability of imipramine to protect against type A or type B monoamine oxidase inhibition by pargyline
R W Fuller, S K Hemrick
Biochemical and Biophysical Research Communications
|
June 18, 1974
Increased conversion of a phenylalanine load to tyrosine in tetraiodoglucagon-treated rats
R W Fuller, J C Baker
BMJ Open
|
February 22, 2023
Cohort study assessing the impact of COVID-19 on venous leg ulcer management and associated clinical outcomes in clinical practice in the UK
Julian F Guest, Graham W Fuller
Comparative Biochemistry and Physiology. B, Comparative Biochemistry
|
October 15, 1973
Binding of tryptophan to plasma proteins in several species
R W Fuller, B W Roush
The Journal of Pharmacy and Pharmacology
|
November 1, 1977
Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors
R W Fuller, K W Perry
The European Respiratory Journal
|
September 1, 1989
The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness
P M O'Byrne, R W Fuller
The Journal of Burn Care & Rehabilitation
|
November 1, 1988
Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey
F W Fuller, P E Engler
The Journal of Pharmacy and Pharmacology
|
March 1, 1979
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine
R W Fuller, H D Snoddy
Page
of 94